FDA-cleared profile

Brainlab Elements Image Fusion, Contouring (4.5);Image Fusion (4.5);Fibertracking (2.0);BOLD MRI Mapping (1.0);Image Fusion Angio (1.0)

Brainlab AG · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

Authorized purpose: Brainlab Elements are software applications for processing medical-image data to support image-guided surgery and radiation-treatment planning; the exact submission includes contouring, rigid and deformable image fusion, DTI fiber tracking, task-based BOLD MRI mapping, and cerebrovascular image co-registration.

Clinical role
Views and processes DICOM images, performs registration, segmentation, fiber tracking, BOLD mapping, and 3D visualization for professional planning and review.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Patient medical-image data for image-guided surgery and radiation-treatment planning, including cranial white matter, task-based BOLD MRI, and cerebrovascular data
Key limitation
Keep in mind: The exact supported applications, modalities, anatomy, protocols, options, and review path are submission-specific; outputs require professional review and do not establish a general product-wide sensitivity or specificity.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Brainlab Elements are software applications for processing medical-image data to support image-guided surgery and radiation-treatment planning; the exact submission includes contouring, rigid and deformable image fusion, DTI fiber tracking, task-based BOLD MRI mapping, and cerebrovascular image co-registration.
  • Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: Patient medical-image data for image-guided surgery and radiation-treatment planning, including cranial white matter, task-based BOLD MRI, and cerebrovascular data Input: DICOM medical-image data from the supported image-guided surgery and radiation-treatment planning workflows, including MRI, angiographic, and diffusion data where applicable.
  • Who uses it?Intended users: Trained radiologists, neurosurgeons, radiation oncologists, radiation therapists, and other qualified healthcare professionals using image-guided planning workflows.
  • What does the software produce?Output: 2D and 3D views, co-registrations, segmentations, fiber tracks, BOLD activation maps, and a 3D DICOM segmentation object for downstream professional use.
  • What is its most important limitation?Key limitation: The exact supported applications, modalities, anatomy, protocols, options, and review path are submission-specific; outputs require professional review and do not establish a general product-wide sensitivity or specificity.

Clinical takeaway. Clinical role: Brainlab Elements are software applications for processing medical-image data to support image-guided surgery and radiation-treatment planning; the exact submission includes contouring, rigid and deformable image fusion, DTI fiber tracking, task-based BOLD MRI mapping, and cerebrovascular image co-registration.

Evidence takeaway. Evidence from the reviewed source record: The K223106 FDA decision material supports the exact Elements 6.0 applications and submission-specific verification or validation; it does not establish a general product-wide sensitivity, specificity, clinical outcome, or current deployment topology.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Brainlab Elements are software applications for processing medical-image data to support image-guided surgery and radiation-treatment planning; the exact submission includes contouring, rigid and deformable image fusion, DTI fiber tracking, task-based BOLD MRI mapping, and cerebrovascular image co-registration.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Views and processes DICOM images, performs registration, segmentation, fiber tracking, BOLD mapping, and 3D visualization for professional planning and review.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Medical-image viewing, processing, segmentation, measurement, registration, communication, or planning support within the exact labeled scope.

Required input
DICOM medical-image data from the supported image-guided surgery and radiation-treatment planning workflows, including MRI, angiographic, and diffusion data where applicable.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: DICOM or other medical-image data from the exact labeled modalities, scanners, and user workflow.

Output and clinician action
2D and 3D views, co-registrations, segmentations, fiber tracks, BOLD activation maps, and a 3D DICOM segmentation object for downstream professional use.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Images, measurements, segmentations, models, reports, or planning information for professional review.

Care setting
Healthcare institution, clinical image-review, surgical-planning, or other labeled environment.
  • Exact FDA submission
  • Checked 2026-09-04
Intended users
Trained radiologists, neurosurgeons, radiation oncologists, radiation therapists, and other qualified healthcare professionals using image-guided planning workflows.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Trained healthcare professionals, physicians, technicians, surgeons, or other users specified by the exact submission.

Limitations
The exact supported applications, modalities, anatomy, protocols, options, and review path are submission-specific; outputs require professional review and do not establish a general product-wide sensitivity or specificity.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: Supported modalities, modules, anatomy, patient population, and output use are submission-specific; source images and generated results require expert review.

Evidence summary
The K223106 FDA decision material supports the exact Elements 6.0 applications and submission-specific verification or validation; it does not establish a general product-wide sensitivity, specificity, clinical outcome, or current deployment topology.
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: The exact FDA decision material for K223106 supports the submission-specific intended use and regulatory verification summarized here; it does not establish a general product-wide sensitivity or specificity value.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The K223106 FDA decision material supports the exact Elements 6.0 applications and submission-specific verification or validation; it does not establish a general product-wide sensitivity, specificity, clinical outcome, or current deployment topology.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Prior source-backed dossier value: The exact FDA decision material for K223106 supports the submission-specific intended use and regulatory verification summarized here; it does not establish a general product-wide sensitivity or specificity value.

Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

No exact-submission and version-linked sensitivity endpoint is promoted; candidate or product-family values were not substituted. Sensitivity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-04

No exact-submission and version-linked specificity endpoint is promoted; candidate or product-family values were not substituted. Specificity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, and source if later verified.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

FDA submission-specific verification and validation evidence for K223106

  • DesignFDA 510(k) regulatory decision material and submission-specific verification or validation evidence for K223106; this is regulatory evidence, not an independent clinical effectiveness study.
  • PopulationThe labeled population, anatomy, images, and test materials described in the exact FDA decision material for K223106; a broader clinical population is not established here.
  • Scopeexact submission
  • Tested versionBrainlab Elements Image Fusion, Contouring (4.5);Image Fusion (4.5);Fibertracking (2.0);BOLD MRI Mapping (1.0);Image Fusion Angio (1.0) (K223106)
  • IndependenceSponsor or vendor study

K223106

The exact FDA material is submission-specific and should not be generalized to other versions, enabled options, sites, protocols, or clinical outcomes.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K223106 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM medical-image data from the supported image-guided surgery and radiation-treatment planning workflows, including MRI, angiographic, and diffusion data where applicable.

    Scope: Exact FDA submission. Prior source-backed dossier value: DICOM or other medical-image data from the exact labeled modalities, scanners, and user workflow.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) decision material K223106: Brainlab Elements Image Fusion, Contouring (4.5);Image Fusion (4.5);Fibertracking (2.0);BOLD MRI Mapping (1.0);Image Fusion Angio (1.0)

  2. Routing

    Source context, not route validation: The exact FDA material describes processing of medical-image data and DICOM-supported modules; local image import, export, treatment-planning connection, identity, and display require confirmation.

    Scope: Exact FDA submission. This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-04 · FDA 510(k) decision material K223106: Brainlab Elements Image Fusion, Contouring (4.5);Image Fusion (4.5);Fibertracking (2.0);BOLD MRI Mapping (1.0);Image Fusion Angio (1.0)

  3. AI processing

    Unresolved route: Not established for the exact route.

    Scope: Exact FDA submission. Exact deployment topology, hosting, network boundaries, PHI flow, retention, update mechanism, and local operational requirements are not established for this submission. The exact public FDA decision material does not establish the complete deployment topology, hosting responsibility, availability, upgrade path, or service contract.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-04 ·

  4. Returned objects

    Source context, not route validation: 2D and 3D views, co-registrations, segmentations, fiber tracks, BOLD activation maps, and a 3D DICOM segmentation object for downstream professional use.

    Scope: Exact FDA submission. Prior source-backed dossier value: Images, measurements, segmentations, models, reports, or planning information for professional review.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) decision material K223106: Brainlab Elements Image Fusion, Contouring (4.5);Image Fusion (4.5);Fibertracking (2.0);BOLD MRI Mapping (1.0);Image Fusion Angio (1.0)

  5. Viewer/worklist/report

    Unresolved route: 2D and 3D views, co-registrations, segmentations, fiber tracks, BOLD activation maps, and a 3D DICOM segmentation object for downstream professional use.

    Scope: Exact FDA submission. Prior source-backed dossier value: Images, measurements, segmentations, models, reports, or planning information for professional review.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) decision material K223106: Brainlab Elements Image Fusion, Contouring (4.5);Image Fusion (4.5);Fibertracking (2.0);BOLD MRI Mapping (1.0);Image Fusion Angio (1.0)

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Integration
The exact FDA material describes processing of medical-image data and DICOM-supported modules; local image import, export, treatment-planning connection, identity, and display require confirmation.
  • Exact FDA submission
  • Checked 2026-09-04

This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.

Training
Only Trained radiologists, neurosurgeons, radiation oncologists, radiation therapists, and other qualified healthcare professionals using image-guided planning workflows should operate or interpret the product; local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-04
Monitoring
Monitor K223106 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: The exact supported applications, modalities, anatomy, protocols, options, and review path are submission-specific; outputs require professional review and do not establish a general product-wide sensitivity or specificity.
  • Exact FDA submission
  • Checked 2026-09-04

Buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.

Workflow role

Medical-image viewing, processing, segmentation, measurement, registration, communication, or planning support within the exact labeled scope.

exact submission · checked 2026-09-04

Submission-anchored workflow summary, not a local acceptance or deployment result.

Input

DICOM or other medical-image data from the exact labeled modalities, scanners, and user workflow.

exact submission · checked 2026-09-04

Exact supported inputs and protocol limits must be confirmed from the complete labeling.

Output

Images, measurements, segmentations, models, reports, or planning information for professional review.

exact submission · checked 2026-09-04

Output review, editing, approval, export, and downstream use remain release- and site-specific.

Deployment evidence

Exact deployment topology and operational boundaries remain unestablished.

exact submission · checked 2026-09-04

Confirm hosting, PHI flow, retention, access, updates, downtime, and support obligations before procurement or clinical use.

Integration evidence

The exact FDA material describes processing of medical-image data and DICOM-supported modules; local image import, export, treatment-planning connection, identity, and display require confirmation.

exact submission · checked 2026-09-04

Validate the local workflow against the exact release and enabled options.

Vendor family context

Current vendor material is product-family context for K223106 only; exact release, enabled options, deployment, security, interoperability, pricing, and local workflow require confirmation.

product family · checked 2026-09-04

Vendor material is not exact-release evidence unless that linkage is separately proven.

Release and scope verification

Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K223106 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Deployment boundary

The exact public deployment topology remains incomplete; establish hosting responsibility, data flow, availability, upgrade, service, and downtime boundaries locally.

exact submission · checked 2026-09-04

FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA material describes DICOM transfer to and from PACS or storage, image viewing and processing, co-registration, segmentation, and 3D DICOM output.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The exact supported applications, modalities, anatomy, protocols, options, and review path are submission-specific; outputs require professional review and do not establish a general product-wide sensitivity or specificity.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.

Lifecycle monitoring

Monitor K223106 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K223106
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Patient medical-image data for image-guided surgery and radiation-treatment planning, including cranial white matter, task-based BOLD MRI, and cerebrovascular data
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-07-14
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-04Last searched
33Fields reviewed
12Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads

Screened 20 PubMed and 10 ClinicalTrials.gov records. The records are generic image-fusion or unrelated clinical studies and do not identify the exact Brainlab Elements applications, tested versions, or K223106; all 30 were quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, vendor product page, implementation documentation, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public exact-release price, license fee, subscription, contract, or implementation cost was established in this review. No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Deployment: Not publicly available - checked 2026-09-04 - Exact FDA submission

    Exact deployment topology, hosting, network boundaries, PHI flow, retention, update mechanism, and local operational requirements are not established for this submission. The exact public FDA decision material does not establish the complete deployment topology, hosting responsibility, availability, upgrade path, or service contract.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-09-04 - Exact FDA submission

    Public sources reviewed here do not establish the complete exact-release security posture, including identity, audit, encryption, retention, remote access, vulnerability management, backup, or incident response. Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

7 sources - 3 history items

Source ledger

  1. FDA 510(k) decision material K223106: Brainlab Elements Image Fusion, Contouring (4.5);Image Fusion (4.5);Fibertracking (2.0);BOLD MRI Mapping (1.0);Image Fusion Angio (1.0)

    U.S. Food and Drug Administration - Published 2023-07-14 - Accessed 2026-09-04

    Scope: identity, productIdentity, purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Brainlab Elements family context

    Brainlab AG - Accessed 2026-09-04

    Scope: productFamilyContext

Research history

  1. K223106 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252708

Relu Cloud

Relu BV

Authorized purpose: Relu Cloud manages, transfers, analyzes, displays, enhances, and stores oral and maxillofacial images and provides design input for dental solutions.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Oral and maxillofacial anatomy
Decision
2026-04-10
FDA-cleared K250237

InferOperate Suite

Beijing Infervision Healthcare Medical Technology Co., Ltd.

Authorized purpose: InferOperate Suite supports trained healthcare professionals in reading, interpreting, reporting, and treatment planning from medical images, with the submission's machine-learning functions applied to adult chest, abdomen, and pelvis CT.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Chest; abdomen; pelvis; and general patient anatomy represented in supported images
Decision
2025-09-15
FDA-cleared K250005

Clever One

Ewoosoft Co., Ltd

Authorized purpose: Clever One is dental imaging software for trained professionals to view and interpret DICOM images from CT, panoramic, cephalometric, intraoral, and other imaging equipment, with two-dimensional analysis and three-dimensional visualization tools.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Dental and craniomaxillofacial anatomy
Decision
2025-05-23

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history